PHARMACOLOGICAL ANTAGONISM OF LETHAL EFFECTS INDUCED BY O-ISOBUTYL S-[2-(DIETHYLAMINO)ETHYL]- METHYLPHOSPHONOTHIOATE

REFERENCES

• Szafraniec L.L., Beaudry W.T., Szafraniec L.J. Decontamination Chemistry of Russian VX. Proceedings of the Scientific Conference on Chemical and Biological Defense Research, Aberdeen Proving Ground, , Maryland, November, 14–17995
   Google Scholar
• Maynard R.L., Beswick F.W. Organophosphorus Compounds as Chemical Warfare Agents. Clinical and Experimental Toxicology of Organophosphates and Carbamates, B. Ballantyne, T.C. Marrs. Butterworth-Heinemann, Oxford 1992; 373–385
   Google Scholar
• Maxwell D.M., Brecht K.M., Koplovitz I. Characterization and Treatment of the Toxicity of O-Isobutyl S-[2-(Diethylamino)ethyl]methylphosphonothioate, a Structural Isomer of VX, in Guinea Pigs. J. Am. Coll. Toxicol. 1997; 15(2)S78–S88
   Google Scholar
• Chang F.-C.T., Gouty S.C., Eder L.C., Hoffman B.E., Maxwell D.M., Brecht K.M. Cardiorespiratory Effects of O-Isobutyl S-[2-(Diethylamino) ethyl]methylphosphonothioate—A Structural Isomer of VX. J. Appl. Toxicol. 1998; 18: 337–347
   PubMed Web of Science ®Google Scholar
• Chang F.-C.T., Gouty S.C., Hoffman B., Eder L.C. A Comparison of Pathophysiology Induced by Soman, VX, and O-Isobutyl S-[2-(Diethylamino) ethyl]methylphosphonothioate. Proceedings of 1998 U.S. Army Medical Research Institute of Chemical Defense Bioscience Review, Aberdeen Proving Ground, , Maryland, May 31–Jun. 4, 1998
   Google Scholar
• Dunn M.A., Sidell F.R. Progress in Medical Defense Against Nerve Agents. J. Amer. Med. Ass. 1989; 262: 649–652
   PubMed Web of Science ®Google Scholar
• Keeler J.R., Hurst C.G., Dunn M.A. Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions. J. Amer. Med. Assoc. 1991; 266: 693–695
   PubMed Web of Science ®Google Scholar
• Leadbeater L., Inns R.H., Rylands J.M. Treatment of Poisoning by Soman. Fund. Appl. Toxicol. 1985; 5: S225–S231
   PubMedGoogle Scholar
• Dirnhuber P., French M.C., Green D.M., Leadbeater L., Stratton J.A. The Protection of Primates Against Soman Poisoning by Pretreatment with Pyridostigmine. J. Pharm. Pharmacol. 1979; 31: 295–299
   PubMed Web of Science ®Google Scholar
• Gordon J.J., Leadbeater L., Maidment M.P. The Protection of Animals Against Organophosphate Poisoning by Pretreatment with a Carbamate. Toxicol. Appl. Pharmacol. 1978; 43: 207–216
   PubMed Web of Science ®Google Scholar
• Chang F.-C.T., Harper R.M. A Procedure for Chronic Recording of Diaphragmatic Electromyographic Activity. Brain Res. Bull. 1989; 22: 561–563
   PubMed Web of Science ®Google Scholar
• Chang F.-C.T., Benton B.J., Salyer J.L., Foster R.E., Franz D.R. Respiratory and Cardiovascular Effects of Tetrodotoxin (TTX) in Urethane-Anesthetized Guinea Pigs. Brain Res. 1990; 528: 259–268
   PubMed Web of Science ®Google Scholar
• Childers D.G. Modern Spectrum Analysis. IEEE Press, New York 1978
   Google Scholar
• McDonough J.H., Jaax N.K., Crowley R.A., Mays M.Z., Modrow H.E. Atropine and/or Diazepam Therapy Protects Against Soman-Induced Neural and Cardiac Pathology. Fundam. Appl. Toxicol. 1989; 13: 256–276
   PubMedGoogle Scholar
• Smith J.C., Ellenberger H.H., Ballanyi K., Richter D.W., Feldman J.L. Pre-Bötzinger Complex: A Brainstem Region that may Generate Respiratory Rhythm in Mammals. Science 1991; 254: 726–728
   PubMed Web of Science ®Google Scholar
• Fedorko L., Merrill E.G. Axonal Projections from the Rostral Expiratory Neurons of the Bötzinger Complex to Medulla and Spinal Cord in the Cat. J. Physiol. 1984; 350: 487–496
   PubMed Web of Science ®Google Scholar
• Merrill E.G., Lipski J., Kubin L., Fedorko L. Origin of the Expiratory Inhibition of Nucleus Tractus Solitarius Inspiratory Neurons. Brain Res. 1983; 263: 43–50
   PubMed Web of Science ®Google Scholar
• Merrill E.G., Fedorko L. Monosynaptic Inhibition of Phrenic Motoneurons: A Long Descending Projection from Bötzinger Neurons. J. Neurosci. 1984; 4: 2350–2353
   PubMed Web of Science ®Google Scholar
• Otake K., Sasaki H., Mannen H., Ezure K. Morphology of Expiratory Neurons of the Bötzinger Complex: An HRP Study in the Cat. J. Comp. Neurol. 1987; 258: 565–579
   PubMed Web of Science ®Google Scholar
• Control of Breathing, Parts I and II. Handbook of Physiology. Sect. 3:The Respiratory System, A.P. Fishman, N.S. Cherniack, J.G. Widdicombe, S.R. Geiger. American Physiological Society, Bethesda 1986; Vol. II
   Google Scholar
• Cherniack N.S., Edelman N.H., Lahiri S. Hypoxia and Hypercapnia as Respiratory Stimulants and Depressants. Respiration Physiol. 1971; 11: 113–126
   Google Scholar
• Capacio B.R., Shih T.-M. Anticonvulsant Actions of Anticholinergic Drugs in Soman Poisoning. Epilepsia 1991; 32: 604–615
   PubMed Web of Science ®Google Scholar
• Jovic R., Milosevic M. Effective Doses of Some Cholinolytics in the Treatment of Anticholinesterase Poisoning. Eur. J. Pharmacol. 1970; 12: 85–93
   PubMed Web of Science ®Google Scholar
• Lipp J.A., Dola T.J. Effect of Atropine Upon the Cerebrovascular System During Soman-Induced Respiratory Depression. Arch. Int. Pharmacodyn. Ther. 1978; 235: 211–218
   PubMedGoogle Scholar
• McDonough J.H., Shih T.-M. Pharmacological Modulation of Soman-Induced Seizures. Neurosci. Biobehav. Rev. 1993; 17: 203–215
   PubMed Web of Science ®Google Scholar
• Wescoe W.C., Green R.E., McNamara B.P., Krop S. The Influence of Atropine and Scopolamine in the Central Effects of DFP. J. Pharmacol. Exp. Ther. 1948; 92: 63–72
   PubMed Web of Science ®Google Scholar
• Wills J.H. Pharmacological Antagonists of the Anticholinesterase Agents. Cholinesterases and Anticholinesterase Agents; Handbuch der Experimentellen Pharmakologie, G.B. Koelle. Springer-Verlag, Berlin 1963; 883–920
   Google Scholar
• Worek F., Szinicz L. Analysis of Cardiovascular and Respiratory Effects of Various Doses of Soman in Guinea-Pigs: Efficacy of Atropine Treatment. Arch. Int. Pharmacodyn. Ther. 1993; 325: 96–112
   PubMedGoogle Scholar
• Worek F., Kleine A., Falke K., Szinicz L. Arrhythmias in Organophosphate Poisoning: Effect of Atropine and Bispyridinium Oximes. Arch. Int. Pharmacodyn. Ther. 1995; 329: 418–435
   PubMedGoogle Scholar